Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Completed 8Recruiting 4Terminated 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2FED 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Breast 1

Conditions

Prostatic Neoplasms 4Hypogonadism 1

Interventions

Magnetic Resonance Spectroscopy 86pembrolizumab 76Specimen Handling 75enzalutamide 55Radiosurgery 55Radiotherapy 51Docetaxel 50Androgen Antagonists 47Gemcitabine 42Nivolumab 39darolutamide 37Prednisone 35enfortumab vedotin 32Abiraterone Acetate 31Cisplatin 30Biopsy 30Carboplatin 29cabozantinib 28Standard of Care 28apalutamide 27Pluvicto 26abiraterone 25Blood Specimen Collection 25Radiation 23Leuprolide 23Ipilimumab 22X-Rays 18relugolix 17Triptorelin Pamoate 17Surveys and Questionnaires 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Testosterone × Genitourinary × Clear all
NCT06733350 2026-05-14

Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance

Roswell Park Cancer Institute

Phase 4 Recruiting
600 enrolled
Genitourinary

Prostatic Neoplasms

NCT06084338 2025-12-31

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

VA Office of Research and Development

Phase 2 Recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT05011383 2025-07-09

VA-BAT

VA Office of Research and Development

Phase 2 Recruiting
51 enrolled
Genitourinary

Prostatic Neoplasms

NCT04833426 2025-05-02

ENFORCE

Canisius-Wilhelmina Hospital

Phase 3 Recruiting
140 enrolled
Genitourinary

Hypogonadism, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡